Diagnostic Medical Systems SA (PA:ALDMS) — Market Cap & Net Worth
Market Cap & Net Worth: Diagnostic Medical Systems SA (ALDMS)
Diagnostic Medical Systems SA (PA:ALDMS) has a market capitalization of $33.03 Million (€28.25 Million) as of September 20, 2026. Listed on the PA stock exchange, this France-based company holds position #23527 globally and #368 in its home market, demonstrating a 9.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diagnostic Medical Systems SA's stock price €1.09 by its total outstanding shares 25919853 (25.92 Million). Also see ALDMS total asset value for a full breakdown of the balance sheet.
Diagnostic Medical Systems SA Market Cap History: 2015 to 2026
Diagnostic Medical Systems SA's market capitalization history from 2015 to 2026. Data shows change from $81.82 Million to $33.03 Million (-6.61% CAGR). Also see ALDMS cash flow conversion for how efficiently the company converts equity into cash flow.
Diagnostic Medical Systems SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diagnostic Medical Systems SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ALDMS share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.77x
Diagnostic Medical Systems SA's market cap is 0.77 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $61.21 Million | $37.41 Million | -$1.35 Million | 1.64x | N/A |
| 2017 | $43.94 Million | $27.12 Million | -$850.00K | 1.62x | N/A |
| 2018 | $21.64 Million | $24.32 Million | -$5.45 Million | 0.89x | N/A |
| 2019 | $37.27 Million | $31.01 Million | -$3.24 Million | 1.20x | N/A |
| 2020 | $53.33 Million | $32.19 Million | -$5.24 Million | 1.66x | N/A |
| 2021 | $36.97 Million | $36.27 Million | -$3.88 Million | 1.02x | N/A |
| 2022 | $30.61 Million | $35.27 Million | -$6.82 Million | 0.87x | N/A |
| 2023 | $34.39 Million | $44.12 Million | -$4.95 Million | 0.78x | N/A |
| 2024 | $22.73 Million | $46.07 Million | -$2.88 Million | 0.49x | N/A |
| 2025 | $38.48 Million | $50.00 Million | -$167.00K | 0.77x | N/A |
Competitor Companies of ALDMS by Market Capitalization
Companies near Diagnostic Medical Systems SA in the global market cap rankings as of September 20, 2026. Review ALDMS goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Diagnostic Medical Systems SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Diagnostic Medical Systems SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Diagnostic Medical Systems SA's market cap moved from $81.82 Million to $ 33.03 Million, with a yearly change of -6.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €33.03 Million | -14.17% |
| 2025 | €38.48 Million | +69.33% |
| 2024 | €22.73 Million | -33.92% |
| 2023 | €34.39 Million | +12.38% |
| 2022 | €30.61 Million | -17.21% |
| 2021 | €36.97 Million | -30.68% |
| 2020 | €53.33 Million | +43.09% |
| 2019 | €37.27 Million | +72.27% |
| 2018 | €21.64 Million | -50.76% |
| 2017 | €43.94 Million | -28.22% |
| 2016 | €61.21 Million | -25.19% |
| 2015 | €81.82 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Diagnostic Medical Systems SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.03 Million USD |
| MoneyControl | $33.03 Million USD |
| MarketWatch | $33.03 Million USD |
| marketcap.company | $33.03 Million USD |
| Reuters | $33.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Diagnostic Medical Systems SA
Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.